Significant association has been observed between the levels of promoter methylation of RASSF1A and TSLC1 tumor-suppressor genes and the quantity of EBV DNA detected in cancer tissues and in adjacent and distant non-cancerous tissues [78]. This evidence concerns the gene CADM1 and cancer.